- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest
Coverage
The guidance includes new information to help providers, patients, and others learn about drug companies’ expanded access policies with a link to the FDA Reagan-Udall Foundation’s Expanded Access Navigator website. The website includes extensive…
The Reagan-Udall Foundation for the FDA honored the Produce Safety Alliance (PSA) with the Reagan-Udall Foundation Leadership Award, one of its 2025 Innovations in Regulatory Science & Policy awards, at a Dec. 9 ceremony in Washington, D.C.
A remarkably thorough report from the Reagan-Udall Foundation, which was ordered by the FDA’s Center for Veterinary Medicine, is at the center of the conversation. The report outlines a plan for what many consider to be a long-overdue change that could…
This year, NSAC focused on deepening stakeholder engagement around the FDA Food Traceability Rule, working closely with the Reagan-Udall Foundation to explore new possibilities for future food safety improvements and gather industry insights to inform…
Most recently, the Reagan-Udall Foundation for FDA released a report in support of Operation Stork Speed.
These actions follow a July 2025 meeting with the Reagan-Udall Foundation about the use and safety of fluoride products in children.
A roundtable convened by the Reagan-Udall Foundation for the FDA developed recommendations for oncology multi-regional clinical trials (MRCTs).
The Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA) has released a report, titled, Infant Formula Roundtable Series Report on Cross-sector Stakeholder Insights, capturing key insights from a series of four moderated roundtable…
In 2025, Dr. Pazdur received the American Association for Cancer Research (AACR) Enduring Impact Award for Transformative Service to Cancer Science and Medicine, a recognition of his profound influence on oncology research and policy. His honors also…
FDA’s action follows a May–October review that included a Federal Register notice and public meeting organized with the Reagan-Udall Foundation and a docket to gather data on safety, clinical use and alternatives.Read more